Intradermal delivery of IL-12 naked DNA induces systemic NK cell activation and Th1 response in vivo that is independent of endogenous IL-12 production

J Immunol. 1999 Aug 15;163(4):1943-50.

Abstract

In this study four murine IL-12 naked DNA expression plasmids (pIL-12), containing both the p35 and p40 subunits, were shown to induce systemic biological effects in vivo after intradermal injection. Three of the four IL-12 expression vectors augmented NK activity and induced expression of the IFN-gamma and IFN-gamma-inducible Mig genes. Both IL-12 p70 heterodimer and IFN-gamma proteins were documented in the serum within 24 h after intradermal injection of the pIL-12o- plasmid, which also induced the highest level of NK activity in the spleen and liver among the IL-12 constructs. Interestingly, both p40 mRNA expression at the injection site and serum protein levels followed a biphasic pattern of expression, with peaks on days 1 and 5. Subsequent studies revealed that the ability of intradermally injected pIL-12o- to augment NK lytic activity was prevented by administration of a neutralizing anti-IL-12 mAb. Finally, injection of the pIL-12o- into BALB/c IL-12 p40-/- mice also resulted in a biphasic pattern of IL-12 p70 appearance in the serum, and induced IFN-gamma protein and activated NK lytic activity in liver and spleen. These results demonstrate that injection of delivered naked DNA encoding the IL-12 gene mediates the biphasic systemic production of IL-12-inducible genes and augments the cytotoxic function of NK cells in lymphoid and parenchymal organs as a direct result of transgene expression. The results also suggest that these naked DNA plasmids may be useful adjuvants for vaccines against infectious and neoplastic diseases.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adjuvants, Immunologic / administration & dosage
  • Animals
  • Antibodies, Monoclonal / pharmacology
  • Chemokine CXCL9
  • Chemokines, CXC / biosynthesis
  • Chemokines, CXC / genetics
  • Cytomegalovirus / genetics
  • Cytotoxicity, Immunologic / genetics
  • Cytotoxicity, Immunologic / immunology
  • DNA, Viral / administration & dosage*
  • Female
  • Gene Expression Regulation, Viral / immunology
  • Immunosuppressive Agents / pharmacology
  • Injections, Intradermal
  • Intercellular Signaling Peptides and Proteins*
  • Interferon-gamma / biosynthesis
  • Interferon-gamma / blood
  • Interferon-gamma / genetics
  • Interleukin-12 / administration & dosage
  • Interleukin-12 / biosynthesis*
  • Interleukin-12 / genetics*
  • Interleukin-12 / immunology
  • Killer Cells, Natural / immunology*
  • Kinetics
  • Lymphocyte Activation / genetics*
  • Mice
  • Mice, Inbred BALB C
  • Mice, Knockout
  • Plasmids / administration & dosage
  • Plasmids / genetics
  • Plasmids / immunology
  • Spleen / immunology
  • Spleen / metabolism
  • Th1 Cells / metabolism*
  • beta-Galactosidase / administration & dosage
  • beta-Galactosidase / biosynthesis
  • beta-Galactosidase / genetics

Substances

  • Adjuvants, Immunologic
  • Antibodies, Monoclonal
  • CXCL9 protein, human
  • Chemokine CXCL9
  • Chemokines, CXC
  • DNA, Viral
  • Immunosuppressive Agents
  • Intercellular Signaling Peptides and Proteins
  • Interleukin-12
  • Interferon-gamma
  • beta-Galactosidase